Injective INJ
Current Price
$3.01 -4.23%
$0.1300 Daily Range (4.32%)
$3.01$3.14
$31.70M Daily Volume
479 BTC
Vol/MktCap: 10.54%
Market Performance
0.09% Relative BTC Volume
The total volume of Injective is $31.70M over the past 24 hours, compared to $34.00B total Bitcoin volume.
Hourly Moving Average
8 SMA $3.09 -2.47%
13 SMA $3.10 -2.88%
21 SMA $3.10 -2.91%
55 SMA $3.12 -3.56%
144 SMA $3.13 -3.90%
Price Performance
-1.39% 1 Hour Change
$3.01 from $3.05
+0.46% 7 Day Change
$0.0139 from $3.00
-15.00% 14 Day Change
-$0.4515 from $3.46
-36.88% 30 Day Change
-$1.11 from $4.12
All Time High
March 14, 2024
$52.62 -94.28%
-$49.61 vs. now
24H Change
-12.91M USD -4.11%
-195 BTC
Volume and Supply
Total Supply: 100.00M INJ 
100.00M INJ Available100.00% circulating A lower circulating supply may increase over time, reducing scarcity and potentially causing a drop in price. A higher circulating supply is less susceptible to dilution, offering the potential for a more stable price long-term.
Relative Supply Ratio
5.00 x BTC Supply5:1 supply ratio
RSR reflects potential differences in tokenomics, such as inflation rates, utility, or burn mechanisms, which can impact long-term value and scarcity.
Relative Trade Volume
10.31M INJ
traded over past 24 hours
10.31% of circulating supply
A higher trade volume relative to market cap indicates strong market activity and liquidity, while a lower ratio may suggest reduced interest, lower liquidity, or potential price stagnation.
Conversion Tool
Injective AI Market Analysis
Injective (INJ) is currently priced at $3.01, reflecting a 4.52% decline over the last 24 hours. The asset has shown minimal volatility within this period, with a daily range of just 0.14%, indicating a consolidation phase.
Trading volume stands at approximately 31.47 million, corresponding to a volume-to-market cap ratio of 10.44%, suggesting a healthy level of market interest. Despite this, the price has been declining over various moving averages, with the 8 SMA at $3.09 showing a 2.47% decrease, indicating bearish momentum in the short term.
The 1-hour RSI is currently at 28, signaling that INJ is in oversold territory, which might indicate a potential short-term reversal. Conversely, the 7-day RSI sits at 50, reflecting neutral momentum, while the 14-day and 30-day changes at -14.95% and -36.84% respectively indicate a significant bearish trend over a longer timeframe.
Injective's all-time high of $52.62, reached on March 14, 2024, sets a stark contrast to its current valuation, highlighting the considerable drawdown and loss of investor confidence. The persistent downward pressure in both short and medium-term price movements suggests that the current bearish trend is more likely to continue unless there is a significant catalyst or market shift.
Given the oversold conditions indicated by the short-term RSI, there may be a brief opportunity for a bounce; however, the overall trend remains negative. Therefore, the recommendation is to Hold at this stage, monitoring for any potential signals of trend reversal or further declines before making a more decisive action.
Trading volume stands at approximately 31.47 million, corresponding to a volume-to-market cap ratio of 10.44%, suggesting a healthy level of market interest. Despite this, the price has been declining over various moving averages, with the 8 SMA at $3.09 showing a 2.47% decrease, indicating bearish momentum in the short term.
The 1-hour RSI is currently at 28, signaling that INJ is in oversold territory, which might indicate a potential short-term reversal. Conversely, the 7-day RSI sits at 50, reflecting neutral momentum, while the 14-day and 30-day changes at -14.95% and -36.84% respectively indicate a significant bearish trend over a longer timeframe.
Injective's all-time high of $52.62, reached on March 14, 2024, sets a stark contrast to its current valuation, highlighting the considerable drawdown and loss of investor confidence. The persistent downward pressure in both short and medium-term price movements suggests that the current bearish trend is more likely to continue unless there is a significant catalyst or market shift.
Given the oversold conditions indicated by the short-term RSI, there may be a brief opportunity for a bounce; however, the overall trend remains negative. Therefore, the recommendation is to Hold at this stage, monitoring for any potential signals of trend reversal or further declines before making a more decisive action.
Updated 11 minutes ago.
Injective Relative Price at Market Cap of:
Injective TradingView Chart
In The News

ECB targets 2027 digital euro pilot as provider selection begins in Q1 2026
The ECB is set to begin selecting EU-licensed payment providers for its digital euro pilot this quarter, with the 12-month pilot set to kick off in the second half of 2027.

Wirex Launches Visa Direct Stablecoin Push-to-Card for BaaS Clients — Reaching 3B+ Cards
Wirex, a full-stack crypto card issuer and Banking-as-a-Service (BaaS) provider,announced Stablecoin Push-to-Card, powered by Visa Direct.

Singularry AI Unveils Singularry Agent – The Autonomous DeFi Copilot Powering the Future of Finance on BNB Chain
Singularry AI today announces the launch of Singularry Agent, an autonomous DeFi copilot designed to manage, optimize and evolve on-chain portfolios on BNB Chain.

How Europe’s blockchain sandbox finds innovation in regulation
The EU regulated blockchain earlier than most major economies.